Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4G0D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,640
Award facts
- Contract value 100% obligated
- $20,639.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,639.77 to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 Syringe 0.5ML, a human papillomavirus vaccine. The award, issued on January 28, 2026, utilizes firm fixed-price pricing and is not designated as a set-aside contract. The place of performance is located in Conshohocken, Pennsylvania, the vendor's corporate headquarters. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which does business as AmerisourceBergen, and serves as a critical vendor for federal medical procurement across multiple therapeutic domains. The parent company, Cencora, Inc., holds a significant IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, and has demonstrated consistent capability to fulfill government contracts for essential pharmaceutical and medical commodities required by military treatment facilities and veterans' healthcare programs. The vaccine supply order supports the Defense Health Agency and other federal healthcare systems in maintaining medical readiness and troop health protection initiatives.
Quick answers
Who was awarded contract SPE2DR26F4G0D?
SPE2DR26F4G0D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4G0D worth?
The government has obligated $20,640 on SPE2DR26F4G0D.
Is contract SPE2DR26F4G0D an order under another contract?
Yes. SPE2DR26F4G0D is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4G0D competed?
The extent of competition for SPE2DR26F4G0D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award